The endothelium, Part I: Multiple functions of the endothelial cells--focus on endothelium-derived vasoactive mediators

M Félétou - 2011 - books.google.com
The endothelium, a monolayer of endothelial cells, constitutes the inner cellular lining of the
blood vessels (arteries, veins and capillaries) and the lymphatic system, and therefore is in …

Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation

S Masi, M Uliana, A Virdis - Vascular pharmacology, 2019 - Elsevier
Reactive oxygen species (ROS) are oxygen derivates and play an active role in vascular
biology. These compounds are generated within the vascular wall, at the level of endothelial …

[HTML][HTML] Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes

G Passacquale, P Vamadevan, L Pereira, C Hamid… - PloS one, 2011 - journals.plos.org
Background Activated platelets exert a pro-inflammatory action that can be largely ascribed
to their ability to interact with leukocytes and modulate their activity. We hypothesized that …

Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions

A Undas, KE Brummel-Ziedins, KG Mann - Blood, 2007 - ashpublications.org
Aspirin is effective in the prevention of cardiovascular events in high-risk patients. The
primary established effect of aspirin on hemostasis is to impair platelet aggregation via …

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

A Rostom, K Muir, C Dubé, E Jolicoeur… - Clinical …, 2007 - Elsevier
Background & Aims: Nonselective non-steroidal anti-inflammatory drugs (NSAIDs) and
cyclooxygenase-2 inhibitors (COX-2s) are used to treat a variety of arthritic and inflammatory …

Aspirin resistance and atherothrombotic disease

PJ Mason, AK Jacobs, JE Freedman - Journal of the American College of …, 2005 - jacc.org
Acute coronary syndromes and other manifestations of atherothrombotic disease are
primarily caused by atherosclerotic plaque rupture or fissuring and subsequent occlusive or …

[HTML][HTML] Current and novel antiplatelet therapies for the treatment of cardiovascular diseases

G Jourdi, M Lordkipanidze, A Philippe… - International journal of …, 2021 - mdpi.com
Over the last decades, antiplatelet agents, mainly aspirin and P2Y12 receptor antagonists,
have significantly reduced morbidity and mortality associated with arterial thrombosis. Their …

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

F Cipollone, E Toniato, S Martinotti, M Fazia, A Iezzi… - Jama, 2004 - jamanetwork.com
ContextMyocardial infarction (MI) and ischemic stroke are thought to be caused by matrix
digestion by metalloproteinases (MMPs) leading to rupture of atherosclerotic plaques …

[HTML][HTML] Long-chain acyl-CoA synthetase 4 modulates prostaglandin E2 release from human arterial smooth muscle cells

DL Golej, B Askari, F Kramer, S Barnhart… - Journal of lipid …, 2011 - ASBMB
Long-chain acyl-CoA synthetases (ACSLs) catalyze the thioesterification of long-chain FAs
into their acyl-CoA derivatives. Purified ACSL4 is an arachidonic acid (20: 4)-preferring …

Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism

KM Egan, M Wang, MB Lucitt, AM Zukas, E Puré… - Circulation, 2005 - Am Heart Assoc
Background—Antagonism or deletion of the receptor (the TP) for the cyclooxygenase (COX)
product thromboxane (Tx) A2, retards atherogenesis in apolipoprotein E knockout (ApoE …